The Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs are a great way for companies to kick-start their business. However, navigating the …
What you need to know about applying for SBIR/STTR grants Read More »
Since 1999, Joe Panetta has been President & CEO and a board member of Biocom California, the state’s advocate for the life sciences industry. …
How a 2017 IRS tax law could bankrupt small American biotech companies in 2023 Read More »
Hispanic Heritage Month, from September 15 to October 15, serves as an important opportunity to remember and honor the contributions of the Hispanic community …
Legislation to encourage innovation and protect patent holders should not be distorted into instruments for drug price controls, a high-profile group of former judges, …
Top legal experts: Laws protecting IP aren’t tools for drug price controls Read More »
At least three-quarters of U.S. voters favor keeping the Bayh-Dole Act to back innovation and research, but are concerned that it may be “misused …
Poll: U.S. voters support the Bayh-Dole Act, but fear its misuse by lawmakers Read More »
The Biotechnology Innovation Organization (BIO) is surveying biotech companies about their interactions with the Food and Drug Administration (FDA), with the goal of improving …
BIO surveying biotech firms on how to improve communications with the FDA Read More »
Dubbed one of the most significant and inspiring pieces of legislation in the history of innovation and invention in the United States, the Bayh-Dole …
Bayh-Dole Coalition awards 5 innovators for groundbreaking discoveries Read More »
Jennifer Camel-Toueg’s son was not getting better. “Alex, who is now 20 years old, was diagnosed with ulcerative colitis at 17,” recalled Camel-Toueg. “With …
TrueTrials simplifies finding FDA-authorized cell therapy clinical trials Read More »
Drug price controls in the Inflation Reduction Act (IRA) harm the development of new drugs, according to Sept. 20 testimony in Congress from John …
BIO Vice Chair John Crowley to Congress: IRA reduces access to innovative drugs Read More »
The Inflation Reduction Act (IRA) includes a misguided plan to control prices that will only result in costlier medicine and reduced access, lawmakers and …
Why drug price controls ‘risk the future of investment’ in R&D Read More »
